T1	Treatment 67 88	arzoxifene (LY353381)
T2	Treatment 241 289	selective estrogen receptor modulator arzoxifene
T3	Treatment 389 399	arzoxifene
T4	Treatment 584 620	received arzoxifene 20 or 50 mg/day.
T5	Treatment 621 690	Tumor response was assessed using World Health Organization criteria.
T6	Treatment 691 799	Toxicities were graded according to the National Cancer Institute Common Toxicity Criteria (NCI-CTC) system.
T7	Treatment 1226 1236	Arzoxifene
T8	Treatment 1350 1360	arzoxifene
T9	Treatment 1524 1535	arzoxifene.
T10	Treatment 1549 1559	arzoxifene
